Annual CFO
-$7.57 M
+$21.12 M+73.62%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual cash flow from operations is -$7.57 million, with the most recent change of +$21.12 million (+73.62%) on December 31, 2023.
- During the last 3 years, IMNM annual CFO has risen by +$4.57 million (+37.63%).
- IMNM annual CFO is now -2.19% below its all-time high of -$7.41 million, reached on December 31, 2018.
Performance
IMNM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$34.17 M
-$10.77 M-46.03%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly cash flow from operations is -$34.17 million, with the most recent change of -$10.77 million (-46.03%) on September 30, 2024.
- Over the past year, IMNM quarterly CFO has dropped by -$16.71 million (-95.70%).
- IMNM quarterly CFO is now -241.34% below its all-time high of $24.17 million, reached on March 31, 2023.
Performance
IMNM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$86.19 M
-$25.55 M-42.14%
September 30, 2024
Summary
- As of February 7, 2025, IMNM TTM cash flow from operations is -$86.19 million, with the most recent change of -$25.55 million (-42.14%) on September 30, 2024.
- Over the past year, IMNM TTM CFO has dropped by -$78.63 million (-1038.91%).
- IMNM TTM CFO is now -2127.59% below its all-time high of $4.25 million, reached on June 30, 2023.
Performance
IMNM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IMNM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +73.6% | -95.7% | -1038.9% |
| 3 y3 years | +37.6% | -411.3% | -200.4% |
| 5 y5 years | -2.2% | -411.3% | -200.4% |
IMNM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.6% | -241.3% | at low | -2127.6% | at low |
| 5 y | 5-year | at high | +73.6% | -241.3% | at low | -2127.6% | at low |
| alltime | all time | -2.2% | +73.6% | -241.3% | at low | -2127.6% | at low |
Immunome Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$34.17 M(+46.0%) | -$86.19 M(+42.1%) |
| Jun 2024 | - | -$23.40 M(+109.5%) | -$60.64 M(+41.3%) |
| Mar 2024 | - | -$11.17 M(-36.0%) | -$42.91 M(+467.0%) |
| Dec 2023 | -$7.57 M(-73.6%) | -$17.46 M(+102.7%) | -$7.57 M(-335.9%) |
| Sep 2023 | - | -$8.61 M(+52.0%) | $3.21 M(-24.5%) |
| Jun 2023 | - | -$5.67 M(-123.4%) | $4.25 M(+128.7%) |
| Mar 2023 | - | $24.17 M(-461.7%) | $1.86 M(-106.5%) |
| Dec 2022 | -$28.69 M | -$6.68 M(-11.7%) | -$28.69 M(-0.4%) |
| Sep 2022 | - | -$7.57 M(-6.1%) | -$28.81 M(+13.5%) |
| Jun 2022 | - | -$8.06 M(+26.4%) | -$25.39 M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.38 M(-6.3%) | -$21.07 M(+15.6%) |
| Dec 2021 | -$18.23 M(+50.2%) | -$6.80 M(+64.2%) | -$18.23 M(+4.2%) |
| Sep 2021 | - | -$4.14 M(+10.8%) | -$17.48 M(+10.2%) |
| Jun 2021 | - | -$3.74 M(+5.8%) | -$15.87 M(+16.6%) |
| Mar 2021 | - | -$3.54 M(-41.7%) | -$13.61 M(+12.1%) |
| Dec 2020 | -$12.13 M(+26.4%) | -$6.06 M(+139.8%) | -$12.13 M(+99.8%) |
| Sep 2020 | - | -$2.53 M(+70.8%) | -$6.07 M(+71.3%) |
| Jun 2020 | - | -$1.48 M(-28.3%) | -$3.54 M(+71.7%) |
| Mar 2020 | - | -$2.06 M | -$2.06 M |
| Dec 2019 | -$9.60 M(+29.6%) | - | - |
| Dec 2018 | -$7.41 M | - | - |
FAQ
- What is Immunome annual cash flow from operations?
- What is the all time high annual CFO for Immunome?
- What is Immunome annual CFO year-on-year change?
- What is Immunome quarterly cash flow from operations?
- What is the all time high quarterly CFO for Immunome?
- What is Immunome quarterly CFO year-on-year change?
- What is Immunome TTM cash flow from operations?
- What is the all time high TTM CFO for Immunome?
- What is Immunome TTM CFO year-on-year change?
What is Immunome annual cash flow from operations?
The current annual CFO of IMNM is -$7.57 M
What is the all time high annual CFO for Immunome?
Immunome all-time high annual cash flow from operations is -$7.41 M
What is Immunome annual CFO year-on-year change?
Over the past year, IMNM annual cash flow from operations has changed by +$21.12 M (+73.62%)
What is Immunome quarterly cash flow from operations?
The current quarterly CFO of IMNM is -$34.17 M
What is the all time high quarterly CFO for Immunome?
Immunome all-time high quarterly cash flow from operations is $24.17 M
What is Immunome quarterly CFO year-on-year change?
Over the past year, IMNM quarterly cash flow from operations has changed by -$16.71 M (-95.70%)
What is Immunome TTM cash flow from operations?
The current TTM CFO of IMNM is -$86.19 M
What is the all time high TTM CFO for Immunome?
Immunome all-time high TTM cash flow from operations is $4.25 M
What is Immunome TTM CFO year-on-year change?
Over the past year, IMNM TTM cash flow from operations has changed by -$78.63 M (-1038.91%)